Ameriprise
TBRA

Ameriprise’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

Ameriprise’s Portfolio TBRA Stock Details TBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-93
Closed -$1K – 4937
2014
Q3 		$1K Buy
+93
New +$1.84K ﹤0.01% 5658

Other funds holding TBRA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Ameriprise's TBRA Position: Q4 2014 in Review

Ameriprise sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q4 2014, closing a stake of 93 shares — an estimated $1K sold.

Ameriprise first reported a position in TBRA in Q3 2014 and held it in 1 quarter. The position peaked at $1K in Q3 2014. 41 funds tracked by Wall St. Rank hold TBRA as of Q4 2014.

  • Ameriprise reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q4 2014 after selling out during the quarter.
  • Ameriprise sold 93 Tobira Therapeutics, Inc. Common Stock shares in Q4 2014, an estimated $1K.
  • Ameriprise first reported a position in Tobira Therapeutics, Inc. Common Stock in Q3 2014 and held it in 1 quarter.
  • Ameriprise's Tobira Therapeutics, Inc. Common Stock position peaked at $1K in Q3 2014.
  • 41 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q4 2014.

Based on Ameriprise's 13F filing for Q4 2014, filed 13 Feb 2015.